乳腺癌 (BC) 和严重的COVID-19 (C-19) 结果:一个匹配的分析
Marija Sullivan1, Xiudong Lei1, Sharon H Giordano1
1The University of Texas MD Anderson Cancer Center.
Research square
|January 3, 2024
概括
患有乳腺癌 (BC) 的患者与没有癌症的患者具有类似的COVID-19 (C-19) 结果. 然而,最近接受化疗的BC患者面临住院风险增加.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 接受癌症治疗的患者面临严重COVID-19 (C-19) 的更高风险.
- 了解乳腺癌及其治疗对C-19结果的具体影响至关重要.
结论:
- 乳腺癌患者通常面临与一般人群相似的C-19风险.
- 乳腺癌患者最近的化疗显著增加了住院的风险.
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195


